http://www.zibb.com/all/theme/cq/Teva+Pharmaceutical+Industries+Limited Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 10 Nov 2009 21:17:00 GMTTue, 10 Nov 2009 21:17:00 GMT608831http://www.zibb.com/all/theme/cq/Teva+Pharmaceutical+Industries+Limited http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://finance.yahoo.com/news/Teva-Receives-Final-Approval-bw-1569321247.html?x=0&.v=1JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) announced today that the U.S. Food and Drug Administration hashttp://finance.yahoo.com/news/Teva-Receives-Final-Approval-bw-1569321247.html?x=0&.v=1Teva Pharmaceutical Industries LimitedTue, 10 Nov 2009 21:17:00 GMThttp://www.newratings.com/en/main/company_headline.m?id=1985796NEW YORK, November 4 (newratings.com) - Analysts at Jefferies & Co reiterate their "buy" rating on Teva Pharmaceutical Industries Limited (ticker: TEVA). The target price has been reduced from $63 to $61. [more]http://www.newratings.com/en/main/company_headline.m?id=1985796Teva Pharmaceutical Industries LimitedWed, 04 Nov 2009 20:47:50 GMThttp://www.zibb.com/article/5638978/Teva+Pharmaceutical+Industries+Beats+By+a+Penny+Revenue+up+TEVA11/3/2009 - Teva Pharmaceutical Industries (NASDAQ:TEVA) reported Q3 EPS of $0.89, ex-items, beating consensus analyst estimates of $0.88. Revenue for the quarter rose 24.9% year-over-year to $3.55 billion, falling short of consensus estimates of $3.63 billion. President and CEO Shlomo Yanai said,http://www.zibb.com/article/5638978/Teva+Pharmaceutical+Industries+Beats+By+a+Penny+Revenue+up+TEVATeva Pharmaceutical Industries LimitedTue, 03 Nov 2009 09:41:13 GMThttp://biz.yahoo.com/bw/090316/20090316005656.html?.v=1Teva to Present at the Cowen and Company 29th Annual Healthcare Conference. - JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) will host a live audio webcast at the Cowen and Company 29th Annual Healthcare Conference with William Marth, President and Chiefhttp://biz.yahoo.com/bw/090316/20090316005656.html?.v=1Teva Pharmaceutical Industries LimitedMon, 16 Mar 2009 12:07:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=114692&full=1JERUSALEM & MONTVALE, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA - News) and Barr Pharmaceuticals, Inc. (NYSE: BRL - News) announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilitieshttp://www.biospace.com/news_story.aspx?StoryID=114692&full=1Teva Pharmaceutical Industries LimitedTue, 28 Oct 2008 12:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081022/20081022005469.html?.v=2Teva to Report Third Quarter 2008 Financial Results on November 6, 2008. - JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA - News) announced today that it will release its third quarter 2008 financial results on Thursday, November 6, 2008.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081022/20081022005469.html?.v=2Teva Pharmaceutical Industries LimitedWed, 22 Oct 2008 08:41:00 GMThttp://www.bloomberg.com/apps/news?pid=20601103&sid=a_8ubaQNxtGk&refer=newsAug. 22 (Bloomberg) -- Alpharma Inc. rose the most in three years in New York Stock Exchange trading after rejecting a $1.38 billion takeover bid from King Pharmaceuticals Inc., a competing developer of abuse-resistant painkillers.http://www.bloomberg.com/apps/news?pid=20601103&sid=a_8ubaQNxtGk&refer=newsTeva Pharmaceutical Industries LimitedFri, 22 Aug 2008 19:37:23 GMThttp://www.canadianbusiness.com/markets/market_news/article.jsp?content=D923RN200MADISON, N.J. (AP) - Wyeth said Wednesday its second-quarter profit fell 6.3 percent on charges for severance and other costs related to ongoing job cuts, but the drug developer still topped Wall Street expectations and raised its full-year outlook.http://www.canadianbusiness.com/markets/market_news/article.jsp?content=D923RN200Teva Pharmaceutical Industries LimitedThu, 24 Jul 2008 00:11:00 GMThttp://www.news-medical.net/?id=40096Teva Pharmaceutical Industries Ltd and Barr Pharmaceuticals, Inc. announced today that they have signed a definitive agreement under which Teva will acquire Barr, the fourth largest generic drug company worldwide. Teva Pharmaceutical Industries Ltd and Barr Pharmaceuticals, Inc. announced todayhttp://www.news-medical.net/?id=40096Teva Pharmaceutical Industries LimitedFri, 18 Jul 2008 22:02:00 GMThttp://www.pharmaceutical-business-review.com/article_news.asp?guid=A13DFD1D-1DE7-4655-9EDD-DDE58A2DE596AstraZeneca has announced that the US District Court of New Jersey has granted the company's motion for summary judgment of no inequitable conduct.http://www.pharmaceutical-business-review.com/article_news.asp?guid=A13DFD1D-1DE7-4655-9EDD-DDE58A2DE596Teva Pharmaceutical Industries LimitedThu, 03 Jul 2008 15:16:00 GMThttp://www.tradingmarkets.com/.site/news/Stock%20News/1426835/TradingMarkets News for AZN,RBXLF - OUTLOOK AstraZeneca Q1 sales seen up 13 pct as generic outlook easeshttp://www.tradingmarkets.com/.site/news/Stock%20News/1426835/Teva Pharmaceutical Industries LimitedThu, 24 Apr 2008 04:44:44 GMThttp://www.iht.com/articles/ap/2008/04/22/business/NA-FIN-EARNS-US-Wyeth.phpGeneric competition hurts Protonix sales, but Wyeth beats expectations and reaffirms outlookhttp://www.iht.com/articles/ap/2008/04/22/business/NA-FIN-EARNS-US-Wyeth.phpTeva Pharmaceutical Industries LimitedTue, 22 Apr 2008 13:54:14 GMThttp://www.marketwatch.com/news/story/drug-stocks-mixed-astrazeneca-jumps/story.aspx?guid=%7B67825F79-1F9A-4A32-904E-EEEBC923E495%7D&dist=msr_40Drug stocks were mixed in early trading Tuesday as shares of AstraZeneca plc jumped on news that it had reached a deal that should help ward off generic competition for its top-selling drug Nexium until 2014.http://www.marketwatch.com/news/story/drug-stocks-mixed-astrazeneca-jumps/story.aspx?guid=%7B67825F79-1F9A-4A32-904E-EEEBC923E495%7D&dist=msr_40Teva Pharmaceutical Industries LimitedTue, 15 Apr 2008 19:19:15 GMThttp://www.patentbaristas.com/archives/2008/03/20/pfizer-feels-pain-over-celebrex/The Court of Appeals for the Federal Circuit upheld a lower court ruling that Teva Pharmaceutical Industries Ltd. infringed two patents held by Pfizer Inc. for Celebrex, a non-steroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis and rheumatoid arthritis. Pfizer v. Tevahttp://www.patentbaristas.com/archives/2008/03/20/pfizer-feels-pain-over-celebrex/Teva Pharmaceutical Industries LimitedFri, 21 Mar 2008 00:27:29 GMThttp://venturebeat.com/2008/02/26/life-sciences-briefing-tuesday-feb-26-2008/TODAY'S HEADLINES: Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release) Personalized medicine co. Proprius ...http://venturebeat.com/2008/02/26/life-sciences-briefing-tuesday-feb-26-2008/Teva Pharmaceutical Industries LimitedTue, 26 Feb 2008 13:00:54 GMThttp://www.medicalnewstoday.com/articles/97284.phpCompugen Ltd. (NASDAQ:CGEN) announced positive in-vivo results for two novel peptide agonists of the MAS G-protein coupled receptor (GPCR), indicating cardio-protective effects and therapeutic pothttp://www.medicalnewstoday.com/articles/97284.phpTeva Pharmaceutical Industries LimitedThu, 14 Feb 2008 05:33:50 GMThttp://online.wsj.com/article/SB120176964716431687.html?mod=googlenews_wsjWyeth reported a 19% rise in net income on strong drug sales, but issued a downbeat 2008 earnings view as it faces generic competition and moves ahead with job cuts.http://online.wsj.com/article/SB120176964716431687.html?mod=googlenews_wsjTeva Pharmaceutical Industries LimitedThu, 31 Jan 2008 12:57:35 GMThttp://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5406AstraZeneca corporate information, one of the world's leading pharmaceutical companies providing effective prescription drugs and innovative prescription medicines in many important therapeutic areashttp://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5406Teva Pharmaceutical Industries LimitedThu, 01 Jan 1970 00:00:00 GMThttp://www.compliancehome.com/news/FDA/15149.htmlTeva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the Food and Drug Administration has responded to their Citizen Petition regarding COPAXONE (glatiramer acetate injection). The FDA declined to review the CP without comment on the approvability of any Abbreviated New Drughttp://www.compliancehome.com/news/FDA/15149.htmlTeva Pharmaceutical Industries Limitedhttp://www.holdrs.com/holdrs/main/index.asp?Action=Article&Description=Merck+%26amp%3B+Co%2E+Inc+&Image=&newsid={38443704-D9C4-4AAA-9C1D-D3FDF3252904}&symb=MRK&sid=3093NEW YORK, March 9, 2009 /PRNewswire via COMTEX/ -- Article One Partners LLC has discovered new prior art impacting the validity of Merck & Co.'s SINGULAIR U.S. drug patent. A request is being filed today with the U.S. Patent Office to review the patent in a reexamination proceeding.http://www.holdrs.com/holdrs/main/index.asp?Action=Article&Description=Merck+%26amp%3B+Co%2E+Inc+&Image=&newsid={38443704-D9C4-4AAA-9C1D-D3FDF3252904}&symb=MRK&sid=3093Teva Pharmaceutical Industries Limitedhttp://www.pharmacychoice.com/news/article.cfm?Article_ID=332921Mar. 10--Merck & Co. Inc. said very few, if any, of its 12,000 Philadelphia-area jobs would be lost in the $41.1 billion merger it announced yesterday with Schering-Plough Corp., a deal that company executives billed as their answer to meager growth prospects and increasing generic competition.http://www.pharmacychoice.com/news/article.cfm?Article_ID=332921Teva Pharmaceutical Industries Limitedhttp://www.tevapharm.com/pr/2000/pr_268.aspJERUSALEM, Israel, September 7, 2000 - Teva Pharmaceutical Industries, Ltd., (Nasdaq: TEVA) announced today that the Israeli Supreme Court acquitted Eli Hurvitz from all charges relating to tax avoidance by Promedico.http://www.tevapharm.com/pr/2000/pr_268.aspTeva Pharmaceutical Industries Limitedhttp://www.towersemi.com/pages/newsletter_content.asp?intGlobalId=397MIGDAL HAEMEK, Israel – January 06, 2009 – Tower Semiconductor Ltd. (NASDAQ: TSEM; TASE: TSEM), a pure-play independent specialty foundry, today announced that its Board of Directors has nominated Amir Elstein to serve as the new Chairman of the Board.http://www.towersemi.com/pages/newsletter_content.asp?intGlobalId=397Teva Pharmaceutical Industries Limitedhttp://topics.nytimes.com/top/news/business/companies/alpharma-inc/index.html?s=oldest&Alpharma Inc. said today that it had received approval from the Food and Drug Administration to market treatments for baldness, Minoxidil Topical Solution, and for vaginal yeast infections, Miconazole Nitrate Vaginal Cream. Minoxidil is the generic equivalent of Pharmacia & Upjohn Inc.http://topics.nytimes.com/top/news/business/companies/alpharma-inc/index.html?s=oldest&Teva Pharmaceutical Industries Limitedhttp://moneycentral.msn.com/news/ticker/sigdev.aspx?Symbol=US%3aGILDJanuary 29, 2009 Gilead Sciences, Inc. announced that the Company has completed its acquisition from Electronics For Imaging, Inc. of a building located at 301 Velocity Way and adjacent land in Foster City, California.http://moneycentral.msn.com/news/ticker/sigdev.aspx?Symbol=US%3aGILDTeva Pharmaceutical Industries Limited